Novaccess Global Inc XSNX

Healthcare Biotechnology

NovAccess Global Inc. is a biopharmaceutical company, which develops immunotherapies to treat brain tumor patients in the United States. The Company specializes in research related to utilizing a patient’s own immune system to attack the cancer. Its dendritic cell-based immunotherapy utilizes a combination of Toll-like receptor adjuvants for an enhanced antitumor response. The therapy is designed to utilize the patient’s tumor antigens and immune cells, dendritic cells, in combination with TLR adjuvants to initiate an efficient antitumor immune response. This process includes obtaining the patients' tumor cells after surgery, and precursors cells that are matured into dendritic cells from peripheral blood. Its TLR-AD1 platform technology is a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas. TLR-AD1 technology has a scope of use and is embodied in various different product lines for different clinical situations.

OTCPK:XSNX - Post by User

Novaccess Global Inc > THEY NEED A MAJOR COMPANY TO SUPPORT THEM

<< Previous

Bullboard Posts

Next >>

Comment by Peanutbudderon Jan 06, 2018 8:05pm

57 Views

Post# 27298815

RE:THEY NEED A MAJOR COMPANY TO SUPPORT THEM

I agree... have you seen the galleries, the work looks extremely professional. It will only take one to cause a snowball effect. Doesn't look like it takes up any prime company space neither, operates in unused areas. Could have huge savings.. bought at 0.0015 today... you guys can fight over 0.0013 and 0.0014.. parked a few bucks here... this thing sees 5 cents will have a couple or nice toys... speculation play who knows if they will get involved in MJ or not but I'm going to be patient enough to hang around and find out

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 7, 2024